Financial reports
10-Q
2024 Q3
Quarterly report
27 Feb 24
10-Q
2024 Q2
Quarterly report
30 Nov 23
ARS
2023 FY
Annual report to shareholders
13 Sep 23
10-Q
2024 Q1
Quarterly report
31 Aug 23
10-K
2023 FY
Annual report
22 Jun 23
10-Q
2023 Q3
Quarterly report
1 Mar 23
10-Q
2023 Q2
Quarterly report
1 Dec 22
10-Q
2023 Q1
Quarterly report
1 Sep 22
10-K
2022 FY
Annual report
23 Jun 22
10-Q
2022 Q3
Quarterly report
3 Mar 22
Current reports
8-K
Medtronic reports third quarter
20 Feb 24
8-K
Other Events
6 Dec 23
8-K
Medtronic reports second quarter
21 Nov 23
8-K
Departure of Directors or Certain Officers
23 Oct 23
8-K
Medtronic reports first quarter
22 Aug 23
8-K
Medtronic Board appoints Greg Lewis as new Director
26 Jun 23
8-K
Medtronic reports full year and fourth quarter
25 May 23
8-K
Entry into a Material Definitive Agreement
30 Mar 23
8-K
Regulation FD Disclosure
9 Mar 23
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
8 Dec 23
424B5
Prospectus supplement for primary offering
24 Mar 23
FWP
Free writing prospectus
23 Mar 23
424B3
Prospectus supplement
23 Mar 23
25-NSE
Exchange delisting
15 Mar 23
25-NSE
Exchange delisting
10 Mar 23
S-3ASR
Automatic shelf registration
3 Mar 23
25-NSE
Exchange delisting
2 Dec 22
8-A12B
Registration of securities on exchange
21 Sep 22
424B5
Prospectus supplement for primary offering
16 Sep 22
Proxies
DEFA14A
Additional proxy soliciting materials
11 Aug 23
DEF 14A
Definitive proxy
11 Aug 23
DEFA14A
Additional proxy soliciting materials
19 Aug 22
DEF 14A
Definitive proxy
19 Aug 22
DEFA14A
Additional proxy soliciting materials
8 Oct 21
DEFR14A
Revised proxy
8 Oct 21
DEF 14A
Definitive proxy
27 Aug 21
DFAN14A
Additional proxy materials by non-management
6 Aug 21
DFAN14A
Additional proxy materials by non-management
6 Aug 21
DEFA14A
Additional proxy soliciting materials
13 Oct 20
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
31 Aug 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
22 Jun 23
SD
Conflict minerals disclosure
30 May 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Mar 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Dec 22
CERT
Certification of approval for exchange listing
21 Sep 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
23 Jun 22
SD
Conflict minerals disclosure
31 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3 Mar 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
2 Dec 21
Ownership
4
Michael Marinaro
9 Apr 24
4
Michael Marinaro
7 Mar 24
4
Sean Salmon
23 Feb 24
144
Notice of proposed sale of securities
21 Feb 24
5
Orchestra BioMed Holdings, Inc.
14 Feb 24
SC 13G/A
Orchestra BioMed Holdings, Inc.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
12 Feb 24
4
Jennifer M Kirk
2 Feb 24
4
Brett A. Wall
20 Dec 23